The HFE genotype and a formulated diet controlling for iron status attenuate experimental cerebral malaria in mice

International Journal for Parasitology

Volumn 45, Issue 12, 2015, Pages 797-808

  Leitner, Dominique F ^a   Stoute, José A ^a   Landmesser, Mary ^a   Neely, Elizabeth ^a   Connor, James R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Epo; IL 6; Iron; Malaria; Myelin; Sema4A

Indexed keywords

BRAIN; DIET; GENOTYPE; IRON; MALARIA; MORBIDITY; NEUROLOGY; PROTEIN; RODENT;

MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; RODENTIA;

HFE PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; SEMA4A PROTEIN, MOUSE; SEMAPHORIN;

ANIMAL; BRAIN; C57BL MOUSE; DIET; DISEASE MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; MALARIA; METABOLISM; PARASITOLOGY; PATHOLOGY; PLASMODIUM BERGHEI; PROCEDURES; SURVIVAL ANALYSIS;

ANIMALS; BRAIN; DIET; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IRON; MALARIA, CEREBRAL; MEMBRANE PROTEINS; MICE, INBRED C57BL; PLASMODIUM BERGHEI; SEMAPHORINS; SURVIVAL ANALYSIS;

EID: 84944441241     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2015.07.003     Document Type: Article

References (80)

1. AFHSC Update: malaria, U.S. Armed Forces, 2013. MSMR 2014, 21:4-7.
2. Arosa F.A., da Silva A.J., Godinho I.M., ter Steege J.C., Porto G., Rudd C.E., de Sousa M. Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis. Scand. J. Immunol. 1994, 39:426-432.
3. Beard J.L. Effectiveness and strategies of iron supplementation during pregnancy. Am. J. Clin. Nutr. 2000, 71:1288S-1294S.
4. Beard J.L., Wiesinger J.A., Connor J.R. Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev. Neurosci. 2003, 25:308-315.
5. Benesova K., Vujić Spasić M., Schaefer S.M., Stolte J., Baehr-Ivacevic T., Waldow K., Zhou Z., Klingmueller U., Benes V., Mall M.A., Muckenthaler M.U. Hfe deficiency impairs pulmonary neutrophil recruitment in response to inflammation. PLoS One 2012, 7:e39363.
6. Bienvenu A.L., Ferrandiz J., Kaiser K., Latour C., Picot S. Artesunate-erythropoietin combination for murine cerebral malaria treatment. Acta Trop. 2008, 106:104-108.
7. Cardoso C.S., de Sousa M. HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I. Tissue Antigens 2003, 61:263-275.
8. Casals-Pascual C., Idro R., Picot S., Roberts D.J., Newton C.R. Can erythropoietin be used to prevent brain damage in cerebral malaria?. Trends Parasitol. 2009, 25:30-36.
9. Casals-Pascual C., Idro R., Gicheru N., Gwer S., Kitsao B., Gitau E., Mwakesi R., Roberts D.J., Newton C.R. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2634-2639.
10. Clark M.A., Goheen M.M., Cerami C. Influence of host iron status on Plasmodium falciparum infection. Front. Pharmacol. 2014, 5:84.
11. DeMaeyer E., Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat. Q. 1985, 38:302-316.
12. Desruisseaux M.S., Gulinello M., Smith D.N., Lee S.C., Tsuji M., Weiss L.M., Spray D.C., Tanowitz H.B. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J. Infect. Dis. 2008, 197:1621-1627.
13. Dorovini-Zis K., Schmidt K., Huynh H., Fu W., Whitten R.O., Milner D., Kamiza S., Molyneux M., Taylor T.E. The neuropathology of fatal cerebral malaria in malawian children. Am. J. Pathol. 2011, 178:2146-2158.
14. Ehrlich R., Lemonnier F.A. HFE - A novel nonclassical class I molecule that is involved in iron metabolism. Immunity 2000, 13:585-588.
15. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Prass C.E., Quintana L., Starnes S.M., Schatzman R.C., Brunke K.J., Drayna D.T., Risch N.J., Bacon B.R., Wolff R.K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996, 13:399-408.
16. Ganz T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 2009, 21:63-67.
17. Grantham-McGregor S., Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J. Nutr. 2001, 131:649S-666S. Discussion 666S-668S.
18. Hempel C., Combes V., Hunt N.H., Kurtzhals J.A., Grau G.E. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am. J. Pathol. 2011, 179:1939-1950.
19. Hempel C., Hyttel P., Staalsø T., Nyengaard J.R., Kurtzhals J.A. Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria. Malar. J. 2012, 11:216.
20. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
21. Hunt N.H., Grau G.E., Engwerda C., Barnum S.R., van der Heyde H., Hansen D.S., Schofield L., Golenser J. Murine cerebral malaria: the whole story. Trends Parasitol. 2010, 26:272-274.
22. Idro R., Marsh K., John C.C., Newton C.R. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr. Res. 2010, 68:267-274.
23. Janota I., Doshi B. Cerebral malaria in the United Kingdom. J. Clin. Pathol. 1979, 32:769-772.
24. Jonker F.A., Calis J.C., van Hensbroek M.B., Phiri K., Geskus R.B., Brabin B.J., Leenstra T. Iron status predicts malaria risk in Malawian preschool children. PLoS One 2012, 7:e42670.
25. Kaiser K., Texier A., Ferrandiz J., Buguet A., Meiller A., Latour C., Peyron F., Cespuglio R., Picot S. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J. Infect. Dis. 2006, 193:987-995.
26. Kampondeni S.D., Potchen M.J., Beare N.A., Seydel K.B., Glover S.J., Taylor T.E., Birbeck G.L. MRI findings in a cohort of brain injured survivors of pediatric cerebral malaria. Am. J. Trop. Med. Hyg. 2013, 88:542-546.
27. Khan F.A., Fisher M.A., Khakoo R.A. Association of hemochromatosis with infectious diseases: expanding spectrum. Int. J. Infect. Dis. 2007, 11:482-487.
28. Koka S., Föller M., Lamprecht G., Boini K.M., Lang C., Huber S.M., Lang F. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem. Biophys. Res. Commun. 2007, 357:608-614.
29. Kumanogoh A., Marukawa S., Suzuki K., Takegahara N., Watanabe C., Ch'ng E., Ishida I., Fujimura H., Sakoda S., Yoshida K., Kikutani H. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002, 419:629-633.
30. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:725-732.
31. Lebrón J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998, 93:111-123.
32. Leitner D.F., Todorich B., Zhang X., Connor J.R. Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis. ASN Neuro 2015, 7:1-13.
33. Li R., Luo C., Mines M., Zhang J., Fan G.H. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J. Biol. Chem. 2006, 281:37616-37627.
34. Lozoff B., Georgieff M.K. Iron deficiency and brain development. Semin. Pediatr. Neurol. 2006, 13:158-165.
35. Lozoff B., Beard J., Connor J., Barbara F., Georgieff M., Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr. Rev. 2006, 64:S34-43.
36. Lyke K.E., Burges R., Cissoko Y., Sangare L., Dao M., Diarra I., Kone A., Harley R., Plowe C.V., Doumbo O.K., Sztein M.B. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 2004, 72:5630-5637.
37. Ma N., Madigan M.C., Chan-Ling T., Hunt N.H. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia 1997, 19:135-151.
38. Macdougall I.C., Cooper A.C. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol. Dial. Transplant. 2002, 17(Suppl. 11):39-43.
39. Medana I.M., Chaudhri G., Chan-Ling T., Hunt N.H. Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology?. Immunol. Cell Biol. 2001, 79:101-120.
40. Merryweather-Clarke A.T., Pointon J.J., Jouanolle A.M., Rochette J., Robson K.J. Geography of HFE C282Y and H63D mutations. Genet. Test. 2000, 4:183-198.
41. Miranda A.S., Brant F., Rocha N.P., Cisalpino D., Rodrigues D.H., Souza D.G., Machado F.S., Rachid M.A., Teixeira A.L., Campos A.C. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria. Malar. J. 2013, 12:388.
42. Moura E., Verheul A.F., Marx J.J. A functional defect in hereditary haemochromatosis monocytes and monocyte-derived macrophages. Eur. J. Clin. Invest. 1998, 28:164-173.
43. Nairz M., Sonnweber T., Schroll A., Theurl I., Weiss G. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect. 2012, 14:238-246.
44. Nakatsuji Y., et al. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis. J. Immunol. 2012, 188:4858-4865.
45. Nandar W., Neely E.B., Unger E., Connor J.R. A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice. Biochim. Biophys. Acta 2013, 1832:729-741.
46. Neill A.L., Hunt N.H. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 1992, 105(Pt. 2):165-175.
47. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 1973, 21:749-757.
48. Ojukwu J.U., Okebe J.U., Yahav D., Paul M. Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst. Rev. 2009, CD006589.
49. Okebe J.U., Yahav D., Shbita R., Paul M. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst. Rev. 2011, CD006589.
50. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., Connor J.R. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 2004, 77:681-689.
51. Oski F.A., Honig A.S. The effects of therapy on the developmental scores of iron-deficient infants. J. Pediatr. 1978, 92:21-25.
52. Oski F.A., Honig A.S., Helu B., Howanitz P. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Pediatrics 1983, 71:877-880.
53. Pak M., Lopez M.A., Gabayan V., Ganz T., Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108:3730-3735.
54. Patel J.R., McCandless E.E., Dorsey D., Klein R.S. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11062-11067.
55. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., Torti F.M., Torti S.V., Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529-542.
56. Porto G., Reimão R., Gonçalves C., Vicente C., Justiça B., de Sousa M. Haemochromatosis as a window into the study of the immunological system: a novel correlation between CD8+ lymphocytes and iron overload. Eur. J. Haematol. 1994, 52:283-290.
57. Prentice A.M. Iron metabolism, malaria, and other infections: what is all the fuss about?. J. Nutr. 2008, 138:2537-2541.
58. Regan R.F., Kumar N., Gao F., Guo Y. Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience 2002, 113:985-994.
59. Rest J.R. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:410-415.
60. Riley E.M., Couper K.N., Helmby H., Hafalla J.C., de Souza J.B., Langhorne J., Jarra W.B., Zavala F. Neuropathogenesis of human and murine malaria. Trends Parasitol. 2010, 26:277-278.
61. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., Dhingra U., Kabole I., Deb S., Othman M.K., Kabole F.M. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367:133-143.
62. Schonberg D.L., Goldstein E.Z., Sahinkaya F.R., Wei P., Popovich P.G., McTigue D.M. Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J. Neurosci. 2012, 32:5374-5384.
63. Sloane A.J., Raso V., Dimitrov D.S., Xiao X., Deo S., Muljadi N., Restuccia D., Turville S., Kearney C., Broder C.C., Zoellner H., Cunningham A.L., Bendall L., Lynch G.W. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses. Immunol. Cell Biol. 2005, 83:129-143.
64. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
65. Stevenson M.M., Gros P., Olivier M., Fortin A., Serghides L. Cerebral malaria: human versus mouse studies. Trends Parasitol. 2010, 26:274-275.
66. Todorich B., Zhang X., Connor J.R. H-ferritin is the major source of iron for oligodendrocytes. Glia 2011, 59:927-935.
67. Todorich B., Zhang X., Slagle-Webb B., Seaman W.E., Connor J.R. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J. Neurochem. 2008, 107:1495-1505.
68. Tomatsu S., Orii K.O., Fleming R.E., Holden C.C., Waheed A., Britton R.S., Gutierrez M.A., Velez-Castrillon S., Bacon B.R., Sly W.S. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15788-15793.
69. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
70. van Asbeck B.S., Marx J.J., Struyvenberg A., Verhoef J. Functional defects in phagocytic cells from patients with iron overload. J. Infect. 1984, 8:232-240.
71. van Asbeck B.S., Verbrugh H.A., van Oost B.A., Marx J.J., Imhof H.W., Verhoef J. Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br. Med. J. (Clin. Res. Ed.) 1982, 284:542-544.
72. Wang L., Johnson E.E., Shi H.N., Walker W.A., Wessling-Resnick M., Cherayil B.J. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 2008, 181:2723-2731.
73. Wang L., Harrington L., Trebicka E., Shi H.N., Kagan J.C., Hong C.C., Lin H.Y., Babitt J.L., Cherayil B.J. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J. Clin. Invest. 2009, 119:3322-3328.
74. Wei X., Li Y., Sun X., Zhu X., Feng Y., Liu J., Jiang Y., Shang H., Cui L., Cao Y. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Infect. Immun. 2014, 82:165-173.
75. Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu. Rev. Nutr. 2010, 30:105-122.
76. WHO Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 2000, 94(Suppl. 1):S1-S90.
77. Wiese L., Hempel C., Penkowa M., Kirkby N., Kurtzhals J.A. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar. J. 2008, 7:3.
78. Zarychanski R., Houston D.S. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?. CMAJ 2008, 179:333-337.
79. Zhang X., Surguladze N., Slagle-Webb B., Cozzi A., Connor J.R. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 2006, 54:795-804.
80. Zlotkin S., Newton S., Aimone A.M., Azindow I., Amenga-Etego S., Tchum K., Mahama E., Thorpe K.E., Owusu-Agyei S. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA 2013, 310:938-947.